Denali Therapeutics Inc. (DNLI) quarterly cash flow statement — complete operating, investing & financing history
Denali Therapeutics Inc. (DNLI) cash flow statement — 11-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -117.44M | -97M | -131.2M | -98.54M | -107.3M | -75.3M | -131.47M | -83.72M | -59.14M | -91.22M | -113.62M | -98.66M | -87.36M | -113.17M | -58.8M | -72.66M | -57.05M | -42.9M | -72.11M | -65.49M |
| Operating CF Margin % | -660.61% | -2691.51% | - | - | - | - | - | - | - | - | - | - | -6895.26% | -38.48% | -167.33% | -706.63% | -1602.87% | -81.74% | -171.11% | -523.37% |
| Operating CF Growth % | -9.46% | -28.82% | 0.2% | -17.71% | -81.43% | 17.45% | -15.71% | 15.15% | 32.31% | 19.39% | -93.22% | -35.77% | -53.14% | -163.81% | 18.45% | -10.95% | -37.68% | 20.88% | -43.53% | -112.74% |
| Net Income | 70.13M | -127.55M | -128.45M | -128.55M | -126.9M | -124.12M | -132.97M | -114.75M | -107.19M | -99.03M | -101.8M | -119.47M | -99.35M | 183.38M | -109.78M | -98.68M | -103.3M | -58.79M | -65.22M | -75.26M |
| Depreciation & Amortization | 3.58M | 2.65M | 2.85M | 3.78M | 3.86M | 3.08M | 3.21M | 2.62M | 2.27M | 1.94M | 2.16M | 2.18M | 2.22M | 1.36M | 10.05M | 3.23M | 1.28M | 1.23M | 1.3M | 1.31M |
| Stock-Based Compensation | 22.86M | 22.91M | 23.09M | 23.95M | 0 | 0 | 25.16M | 25.08M | 0 | 25.1M | 27.84M | 25.99M | 27.46M | 0 | 28.08M | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -190.59M | 637K | -1.19M | -2.74M | 21.96M | 22.45M | -4.94M | -7.21M | 15.43M | -11.08M | -26.01M | -13.2M | -13.28M | 15.04M | -8.73M | 22.13M | 23.94M | 24.43M | 27.77M | 24.52M |
| Working Capital Changes | -23.41M | 4.35M | -27.5M | 5.02M | -6.22M | 23.29M | -21.93M | 10.55M | 30.35M | -8.16M | -15.81M | 5.85M | -4.41M | -312.95M | 21.58M | 655K | 21.04M | -9.77M | -35.96M | -16.06M |
| Change in Receivables | -14.96M | -3.93M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -22.14M | -4.14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 8.9M | 227K | 3.88M | -3.41M | -4.07M | 2.6M | -2.64M | 1.29M | -4.37M | 3.89M | 635K | -2.08M | -3.96M | 4.77M | 3.7M | -1.72M | 1.9M | 839K | 1.25M | -78K |
| Cash from Investing | 16.19M | -104.08M | 94.46M | 20.77M | 57.83M | 157.94M | 18.75M | 172.21M | 93.66M | 98.57M | -453.19M | 73.05M | 100.91M | 168.07M | -92.72M | -127.56M | 15.42M | 88.63M | -117.88M | -40.75M |
| Capital Expenditures | -1.01M | -805K | -2.47M | -1.52M | 1.38M | -4.28M | -5.08M | -5.09M | -3.88M | -4.79M | -2.15M | -2.23M | -2.07M | -5.85M | -2.79M | -4.85M | -6.05M | -2.89M | -4.04M | -3.05M |
| CapEx % of Revenue | 5.68% | 22.34% | - | - | - | - | - | - | - | - | - | - | 163.22% | 1.99% | 7.93% | 47.16% | 169.99% | 5.51% | 9.59% | 24.4% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 186.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 2.59M | 14.98M | 219.04M | 192.13M | -778K | 1.62M | -3.76M | -4.17M | -18.56M | 6.76M | 500.27M | 4.71M | 2.49M | 9.02M | 1.6M | 299.65M | 5.15M | 4.4M | 1.46M | 5.17M |
| Debt Issued (Net) | 0 | 17K | -17K | -16K | -1.36M | -2.43M | -4.36M | -8.32M | -24.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 2.61M | 15.01M | 19.06M | 192.15M | 583K | 4.06M | 595K | 4.16M | 5.46M | 6.76M | 499.25M | 0 | 2.49M | 9.02M | 0 | 299.65M | 5.15M | 4.4M | 1.46M | 5.17M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -22K | -38K | 200M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.02M | 4.71M | 0 | 0 | 1.6M | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -98.66M | -186.1M | 182.3M | 114.36M | -50.24M | 84.26M | -116.48M | 84.32M | 15.96M | 14.11M | -66.53M | -20.91M | 16.04M | 63.84M | -149.91M | 99.43M | -36.47M | 50.13M | -188.52M | -101.08M |
| Free Cash Flow | -118.45M | -97.81M | -133.67M | -100.06M | -105.92M | -79.58M | -136.55M | -88.81M | -63.02M | -96.01M | -115.77M | -100.89M | -89.43M | -119.02M | -61.59M | -77.51M | -63.1M | -45.79M | -76.15M | -68.55M |
| FCF Margin % | -666.29% | -2713.85% | - | - | - | - | - | - | - | - | - | - | -7058.48% | -40.47% | -175.26% | -753.79% | -1772.86% | -87.25% | -180.7% | -547.76% |
| FCF Growth % | -11.83% | -22.91% | 2.11% | -12.67% | -68.06% | 17.11% | -17.95% | 11.98% | 29.53% | 19.34% | -87.97% | -30.16% | -41.74% | -159.92% | 19.12% | -13.08% | -45.69% | 16.73% | -43.57% | -113.37% |
| FCF per Share | -0.62 | -0.52 | -0.72 | -0.57 | -0.61 | -0.46 | -0.80 | -0.52 | -0.37 | -0.57 | -0.77 | -0.73 | -0.65 | -0.84 | -0.45 | -0.58 | -0.51 | -0.37 | -0.62 | -0.56 |
| FCF Conversion (FCF/Net Income) | -1.67x | 0.76x | 1.02x | 0.77x | 0.85x | 0.61x | 0.99x | 0.73x | 0.55x | 0.92x | 1.12x | 0.83x | 0.88x | -0.62x | 0.54x | 0.74x | 0.55x | 0.73x | 1.11x | 0.87x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 181K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1K | 0 | 0 | 4K | 0 | 0 | 0 | 0 | 0 |